MY129370A - New anhydrous crystalline forms of gabapentin - Google Patents

New anhydrous crystalline forms of gabapentin

Info

Publication number: MY129370A
Authority: MY; Malaysia
Prior art keywords: gabapentin; crystalline forms; anhydrous crystalline; new anhydrous; new
Prior art date: 2001-10-09

Application number

Other languages

English (en)

Inventor

Linna R Chen

Suresh R Babu

Claude Jeffrey Calvitt

Brian TOBIAS

Original Assignee

Warner Lambert Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-09

Filing date

2002-10-04

Publication date

2007-03-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34589923&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY129370(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-10-04 Application filed by Warner Lambert Co filed Critical Warner Lambert Co

2007-03-30 Publication of MY129370A publication Critical patent/MY129370A/en

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Indole Compounds (AREA)

MYPI20023726 2001-10-09 2002-10-04 New anhydrous crystalline forms of gabapentin MY129370A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US32837501P	2001-10-09	2001-10-09

Publications (1)

Publication Number	Publication Date
MY129370A true MY129370A (en)	2007-03-30

Family

ID=34589923

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20023726 MY129370A (en)	2001-10-09	2002-10-04	New anhydrous crystalline forms of gabapentin

Country Status (12)

Country	Link
AR (1)	AR036695A1 (es)
DO (1)	DOP2002000474A (es)
GT (1)	GT200200204A (es)
HN (1)	HN2002000283A (es)
MY (1)	MY129370A (es)
PA (1)	PA8555901A1 (es)
PE (1)	PE20030689A1 (es)
SV (1)	SV2004001275A (es)
TW (1)	TWI245033B (es)
UA (1)	UA77021C2 (es)
UY (1)	UY27473A1 (es)
ZA (1)	ZA200402519B (es)

2002
- 2002-03-10 UA UA20040503407A patent/UA77021C2/uk unknown
- 2002-09-25 TW TW91122057A patent/TWI245033B/zh not_active IP Right Cessation
- 2002-09-27 AR ARP020103664 patent/AR036695A1/es unknown
- 2002-10-01 DO DO2002000474A patent/DOP2002000474A/es unknown
- 2002-10-04 PE PE2002000988A patent/PE20030689A1/es not_active Application Discontinuation
- 2002-10-04 MY MYPI20023726 patent/MY129370A/en unknown
- 2002-10-04 HN HN2002000283A patent/HN2002000283A/es unknown
- 2002-10-07 UY UY27473A patent/UY27473A1/es not_active Application Discontinuation
- 2002-10-08 SV SV2002001275A patent/SV2004001275A/es not_active Application Discontinuation
- 2002-10-09 GT GT200200204A patent/GT200200204A/es unknown
- 2002-10-09 PA PA8555901A patent/PA8555901A1/es unknown
2004
- 2004-03-30 ZA ZA200402519A patent/ZA200402519B/xx unknown

Also Published As

Publication number	Publication date
GT200200204A (es)	2003-05-23
SV2004001275A (es)	2004-02-24
PA8555901A1 (es)	2003-06-30
AR036695A1 (es)	2004-09-29
UY27473A1 (es)	2003-05-30
PE20030689A1 (es)	2003-08-11
TWI245033B (en)	2005-12-11
UA77021C2 (en)	2006-10-16
HN2002000283A (es)	2005-02-22
DOP2002000474A (es)	2003-04-15
ZA200402519B (en)	2005-01-24

Similar Documents

Publication	Publication Date	Title
GEP20105036B (en)	2010-07-12	Perindopril
HK1073997A1 (en)	2005-10-28	Administration of agents for the treatment of inflammation
BG108269A (en)	2004-12-30	Pyrazolopyrimidines as therapeutic agents
BG108268A (en)	2005-04-30	Pyrazolopyrimidines as therapeutic agents
EP1769791A3 (en)	2007-07-11	Treatment of Alzheimer's disease with cell cycle inhibitors
IS6069A (is)	2001-09-07	N-cýanómetýlamíð sem próteasalatar
MXPA03010766A (es)	2005-03-07	Nuevos compuestos y composiciones como inhibicores de las catepsinas.
AP2004003025A0 (en)	2004-06-30	New anhydrous crystalline forms of gabapentin
IL163871A0 (en)	2005-12-18	Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
LT1496918T (lt)	2023-05-25	Natrio meta-arsenito naudojimas navikams gydyti
MY129370A (en)	2007-03-30	New anhydrous crystalline forms of gabapentin
PL397022A1 (pl)	2012-03-26	Środek leczniczy
MY136288A (en)	2008-09-30	New process for the synthesis of perindopril and its pharmaceutically acceptable salts
GB0003048D0 (en)	2000-03-29	The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
ITTO20020997A1 (it)	2004-05-16	Procedimento autoalllineato per la fabbricazione di
EP1488800A4 (en)	2006-05-31	MEDICINE FOR THE TREATMENT OF PROTOCOL DISEASES
AU2003208368A1 (en)	2003-09-04	Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases
UA67433A (en)	2004-06-15	Treatment-and-prophylaxis urolit composition
AU2003227519A1 (en)	2003-12-19	The use of milnacipran for the treatment of tension-type headache
AU2003244633A1 (en)	2004-01-23	Methods for the treatment of sinusitis
AU2003222141A8 (en)	2003-10-13	Ctla4 compositions in the treatment of autism
AP2002002566A0 (en)	2002-06-30	Monohydrate of cis-lithium-cynao-4-Ä3-(cyclopentloxy)-4-methoxyphenylÜ cyclohexanecarboxylate
WO2002055064A3 (en)	2002-09-26	Mucopolysaccharidosis therapies
ECSP045042A (es)	2004-04-28	Nuevas formas cristalinas anhidras de la gabapentina
CR7318A (es)	2004-05-17	Nuevas formas cristalinas anhidras de la gabapentina